J&J, Schering OTC Advertising Outpaced DTC Spending In 2003
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson spent approximately 40% more on OTC drug advertising in the first nine months of 2003 than on direct-to-consumer prescription drug advertising